[ORGANIZATION]
COMPASS Pathways plc
Featured in 1 tracked story · first seen
Situations
COMPASS Pathways psilocybin therapy development
2 clusters · 5 sources · last updated
Latest: Compass Pathways prepares FDA submission for psilocybin therapy
Biotechnology company COMPASS Pathways is advancing its lead candidate, COMP360, a synthetic psilocybin formulation designed to treat treatment-resistant depression. In mid-September 2026, the company reported a Q2 finan